Federated Investors Inc. PA boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 50.6% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 50,225 shares of the company’s stock after buying an additional 16,865 shares during the period. Federated Investors Inc. PA’s holdings in Henry Schein were worth $3,648,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Millennium Management LLC boosted its holdings in Henry Schein by 60.6% during the first quarter. Millennium Management LLC now owns 33,082 shares of the company’s stock valued at $2,223,000 after acquiring an additional 12,482 shares during the period. Epoch Investment Partners Inc. lifted its stake in shares of Henry Schein by 37.5% in the first quarter. Epoch Investment Partners Inc. now owns 89,040 shares of the company’s stock valued at $5,984,000 after buying an additional 24,272 shares during the period. Alecta Pensionsforsakring Omsesidigt lifted its stake in shares of Henry Schein by 3.8% in the first quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,513,980 shares of the company’s stock valued at $370,539,000 after buying an additional 200,000 shares during the period. Trust Co. of Oklahoma bought a new stake in shares of Henry Schein in the second quarter valued at about $265,000. Finally, American Century Companies Inc. lifted its stake in shares of Henry Schein by 21.2% in the second quarter. American Century Companies Inc. now owns 2,191,660 shares of the company’s stock valued at $159,202,000 after buying an additional 383,479 shares during the period. 96.65% of the stock is currently owned by hedge funds and other institutional investors.

Several research firms recently weighed in on HSIC. BidaskClub upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Saturday, September 8th. Leerink Swann set a $100.00 target price on shares of Henry Schein and gave the company a “buy” rating in a research note on Tuesday, August 7th. Barrington Research reiterated a “buy” rating and issued a $92.00 target price on shares of Henry Schein in a research note on Tuesday, August 7th. Craig Hallum increased their target price on shares of Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, August 7th. Finally, Robert W. Baird increased their target price on shares of Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a research note on Tuesday, August 7th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and ten have assigned a buy rating to the stock. Henry Schein has an average rating of “Hold” and an average target price of $84.11.

Shares of HSIC opened at $82.87 on Thursday. The stock has a market cap of $12.28 billion, a price-to-earnings ratio of 22.65, a price-to-earnings-growth ratio of 2.31 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.29 and a quick ratio of 0.68. Henry Schein, Inc. has a 12 month low of $62.56 and a 12 month high of $87.99.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Monday, August 6th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.03. The firm had revenue of $3.33 billion during the quarter, compared to analysts’ expectations of $3.31 billion. Henry Schein had a net margin of 3.15% and a return on equity of 20.40%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.88 earnings per share. sell-side analysts anticipate that Henry Schein, Inc. will post 4.12 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also: What is the NASDAQ Stock Market?

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.